A current problem in modern medicine is the development of drug resistance mutations. This occurs when a mutation arises in a patient making him/her resistant to a drug and thus rendering the drug useless in treating a specific disease. Many useful drugs are competitive inhibitors of specific enzymes, and the drug-resistance mutations prevent the binding of the drug. These types of mutations, in addition to preventing competitive inhibitor binding, can also sometimes reduce the activity of the enzyme. Why is that the case?
A) These mutations most likely affect an allosteric site on the enzyme
B) These mutations lower the activation energy of the reaction catalyzed by the enzyme
C) Binding to the competitive inhibitor is essential for the function of the enzyme
D) These mutations most likely change the shape of the active site of the enzyme
Correct Answer:
Verified
Q7: AMP-activated protein kinase (AMPK) is an enzyme
Q8: Carbonic anhydrase (CA), an enzyme widely present
Q9: Kinases are enzymes that can phosphorylate (transfer
Q10: Kinases are enzymes that can phosphorylate (transfer
Q11: Based on the graph below, what are
Q12: The normal body temperature of a bat
Q14: Tacrolimus (FK-506) is a drug that inhibits
Q15: You are working with a specific enzyme-catalyzed
Q16: A new antibiotic has been developed that
Q17: Phosphofructokinase (PFK) is an enzyme that converts
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents